Mariko Takami, Ph.D.
Affiliations: | 2012 | Microbiology and Immunology | Loyola University Chicago, Chicago, IL, United States |
Area:
Immunology, Cell BiologyGoogle:
"Mariko Takami"Parents
Sign in to add mentor| Makio Iwashima | grad student | 2012 | Loyola University Chicago | |
| (Cell biology of Foxp3+ regulatory T cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Takami M, Aoki T, Nishimura K, et al. (2024) Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner. Cancer Research Communications. 4: 446-459 |
| Hara A, Koyama-Nasu R, Takami M, et al. (2020) CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy. Cancer Immunology, Immunotherapy : Cii |
| Aoki T, Takami M, Takatani T, et al. (2020) Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner. Cancer Science |
| Toyoda T, Kamata T, Tanaka K, et al. (2020) Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer. Journal For Immunotherapy of Cancer. 8 |
| Kamata T, Yoshida S, Takami M, et al. (2019) Immunological Features of a Lung Cancer Patient Achieving an Objective Response with Anti-PD-1 Blockade Therapy. Cancer Science |
| Ihara F, Sakurai D, Takami M, et al. (2019) Regulatory T cells induce CD4 NKT cell anergy and suppress NKT cell cytotoxic function. Cancer Immunology, Immunotherapy : Cii |
| Harada K, Ihara F, Takami M, et al. (2019) Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation. Cancer Science |
| Aoki T, Takami M, Takatani T, et al. (2019) Invariant NKT Cells Recognize Leukemia Cells with T-Cell and NK Receptors in a CD1d-Independent Manner Blood. 134: 3225-3225 |
| Tanaka K, Kanesaka Y, Takami M, et al. (2018) Role of leukotriene B4 12-hydroxydehydrogenase in α-galactosylceramide-pulsed dendritic cell therapy for non-small cell lung cancer. Biochemical and Biophysical Research Communications |
| Takami M, Cunha C, Motohashi S, et al. (2018) TGF-β suppresses RasGRP1 expression and supports regulatory T cell resistance against p53-induced CD28-dependent T cell apoptosis. European Journal of Immunology |